Idoxifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C28H30INO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 456UXE9867, chemically known as pyrrolidine, 1-(2-(4-(1-(4-iodophenyl)-2-phenyl-1-butenyl)phenoxy)ethyl)-, (e)- but more generally known as idoxifene, which bears US NIH Compound Identifier 3034011. European Medicines Agency schedules Idoxifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08116MIG. The term IDOXIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). IDOXIFENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule idoxifene under HS 29339990 and SITC 51577. As of Q4 2014, IDOXIFENE remains US FDA's Preferred Term for this commodity. Idoxifene bears US NLM identifiers UMLS ID C0139560 and NCI Concept Code C1406. SMILES: IC1CCC(C(=C(\CC)C2CCCCC2)/C2CCC(OCCN3CCCC3)CC2)CC1.